Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: A retrospective study

Experimental and Therapeutic Medicine

Volumn 7, Issue 1, 2013, Pages 97-102

  Yu, Dan Qing ^a   Wang, Ying ^b   Ma, Gui Zhou ^b   Xu, Rong He ^b   Cai, Zhi Xiong ^b   Ni, Chu Min ^b   Chen, Ping ^b   Zhu, Zhi Dan ^b  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SHANTOU CENTRAL HOSPITAL   (China)

Author keywords

Acute fulminant myocarditis; Arrhythmia; Heart failure; Intravenous immunoglobulin; Left ventricular ejection fraction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; GLUCOCORTICOID; IMMUNOGLOBULIN; VASODILATOR AGENT;

ACUTE FULMINANT MYOCARDITIS; ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIOGENIC SHOCK; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART BUNDLE BRANCH BLOCK; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR DIASTOLIC DIAMETER; LEFT VENTRICULAR SYSTOLIC DIAMETER; MALE; OBSERVATIONAL STUDY; PACEMAKER; RETROSPECTIVE STUDY;

EID: 84887874996     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1372     Document Type: Article

References (36)

1. Magnani JW and Dec GW: Myocarditis: current trends in diagnosis and treatment. Circulation 113: 876-890, 2006.
2. Feldman AM and McNamara D: Myocarditis. N Engl J Med 343: 1388-1398, 2000.
3. Amabile N, Fraisse A, Bouvenot J, et al: Outcome of acute fulminant myocarditis in children. Heart 92: 1269-1273, 2006.
4. Ichikawa R, Sumitomo N, Komori A, et al: The follow-up evaluation of electrocardiogram and arrhythmias in children with fulminant myocarditis. Circ J 75: 932-938, 2011.
5. Wolf HM and Eibl MM: Immunomodulatory effect of immunoglobulins. Clin Exp Rheumatol 14 (Suppl 15): S17-S25, 1996.
6. Rosen FS: Putative mechanisms of the effect of intravenous gamma-globulin. Clin Immunol Immunopathol 67: S41-S43, 1993.
7. Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99: 1091-1100, 1999.
8. Yu Z and Lennon VA: Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 340: 227-228, 1999.
9. Drucker NA, Colan SD, Lewis AB, et al: Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89: 252-257, 1994.
10. Mason JW, O'Connell JB, Herskowitz A, et al: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333: 269-275, 1995.
11. Weller AH, Hall M and Huber SA: Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus-induced myocarditis. Eur Heart J13: 115-119, 1992.
12. Newburger JW, Sanders SP, Burns JC, et al: Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation 79: 1237-1246, 1989.
13. O'Connell JB, Robinson JA, Henkin RE and Gunnar RM: Immunosuppressive therapy in patients with congestive cardiomyopathy and myocardial uptake of gallium-67. Circulation 64: 780-786, 1981.
14. Anderson JL, Fowles RE, Unverferth DV, et al: Immunosuppressive therapy of myocardial inflammatory disease. Initial experience and future trials to define indications for therapy. Eur Heart J8(Suppl): 263-266, 1987.
15. Kishimoto C, Takamatsu N, Kawamata H, et al: Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change. J Am Coll Cardiol 36: 1979-1984, 2000.
16. McNamara DM, Rosenblum WD, et al: Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 95: 2476-2478, 1997.
17. Gullestad L, Aass H, Fjeld JG, et al: Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103: 220-225, 2001.
18. Takeda Y, Yasuda S, Miyazaki S, et al: High-dose immunoglobulin G therapy for fulminant myocarditis. Jap Circ J 62: 871-872, 1998.
19. Nigro G, Bastianon V, Colloridi V, et al: Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 31: 65-69, 2000.
20. Tsai YG, Ou TY, Wang CC, et al: Intravenous gamma-globulin therapy in myocarditis complicated with complete heart block: report of one case. Acta Paediatr Taiwan 42: 311-313, 2001.
21. Shioji K, Matsuura Y, Iwase T, et al: Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thiredoxin: a case report. Circ J 66: 977-980, 2002.
22. Tedeschi A, Airaghi L, Giannini S, et al: High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. J Intern Med 251: 169-173, 2002.
23. Stouffer GA, Sheahan RG, Lenihan DJ, et al: The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulin. Am J Med Sci 326: 369-374, 2003.
24. Kim HS, Sohn S, Park JY and Seo JW: Fulminant myocarditis successfully treated with high-dose immunoglobulin. Int J Cardiol 96: 485-486, 2004.
25. Braun JP, Schneider M, Dohmen P and Döpfmer U: Successful treatment of dilative cardiomyopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist support. J Cardiothorac Vasc Anest 18: 772-774, 2004.
26. Abe S, Okura Y, Hoyano M, et al: Plasma concentrations of cytokines and neurohumoral factors in a case of fulminant myocarditis successfully treated with intravenous immunoglobulin and percutaneous cardiopulmonary support. Circ J 68: 1223-1226, 2004.
27. English RF, Janosly JE, Ettedgui JA and Webber SA: Outcomes for children with acute myocarditis. Cardiol Young 14: 488-493, 2004.
28. Karaaslan S, Oran B, Caliskan U, et al: Hemolysis after administration of high-dose immunoglobulin in a patient with myocarditis. Turk J Haematol 20: 237-240, 2003.
29. Khan MA, Das B, Lohe A and Sharma J: Neonatal myocarditis presenting as an apparent life threatening event. Clin Pediatr (Phila) 42: 649-652, 2003.
30. Robinson JL, Hartling L, Crumley E, et al: A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovascular Disorders 5: 12, 2005.
31. Kishimoto C, Shioji K, Kinoshita M, et al: Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Intern J Cardiol 91: 173-178, 2003.
32. Wang CY, Li Lu F, Wu MH, et al: Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 23: 275-276, 2004.
33. McNamara DM, Holubkov R, Starling RC, et al: Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103: 2254-2259, 2001.
34. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389, 1992.
35. Leung DY, Burns JC, Newburger JW and Geha RS: Reversal of lymphocyte activation in vivo in Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 79: 468-472, 1987.
36. Hosenpud JD, Campbell SM and Mendelson DJ: Interleukin-1-induced myocardial depression in an isolate beating heart preparation. J Heart Transplant 8: 460-464, 1989.